openPR Logo
Press release

Peraso Inc. (NASDAQ: PRSO) Rockets Forward: Ladenburg Thalmann Issues Report Amid Explosive Q2 Growth, mmWave Surge FFIE, GDC, INBS, KAVL

08-22-2024 11:12 PM CET | Energy & Environment

Press release from: ABNewswire

Peraso Inc. (NASDAQ: PRSO) Rockets Forward: Ladenburg Thalmann

Peraso Inc. (NASDAQ: PRSO) has captured the attention of analysts following the release of its robust Q2 2024 financial results. Ladenburg Thalmann, a prominent investment firm, has issued a buy rating and a price target of $3.75, reflecting confidence in the company's growth trajectory. See entire report. [https://thestreetreports.com/wp-content/uploads/2024/08/PRSO-report.pdf]

In its August 2024 update, Ladenburg Thalmann highlighted Peraso's impressive revenue of $4.2 million, which surpassed their projections by $200,000. This performance was driven by substantial gains in both the mmWave and memory segments, with mmWave revenue surging by 180% sequentially. The strong revenue mix also led to higher-than-expected margins.

Looking ahead, Ladenburg Thalmann remains optimistic about Peraso's future, projecting $16 million in revenue for 2025, with mmWave revenues expected to rise by 150% year-over-year to $12 million. The report emphasized Peraso's strategic position in the rapidly growing mmWave market, which could drive significant top-line and bottom-line growth.Peraso presented at the Summer 2024 Investor Summit on August 20 and the Emerging Growth Conference on August 21, [https://youtu.be/8T1wEWCrc-g], further positioning the company for increased investor interest.

Here are four standout companies under $5 demonstrating strong market trends, volume, and heightened awareness:

* Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE): Volume soars as the market responds positively to its new share structure.
* GD Culture Group Limited (NASDAQ: GDC): Stock surges 127% on August 21, 2024, as it announces plans to enter the livestream market through AI Catalysis-a stock to watch now.
* Intelligent Bio Solutions (NASDAQ: INBS): Surpasses 1,000 drug screening reader installations, reflecting 65% annual growth, and is up 24% on increased volume-another stock to watch closely.
* Kaival Brands (NASDAQ: KAVL), the U.S. distributor of BIDI Registered Stick and global distributor of VEEBA Registered through Philip Morris (NYSE: PM), raised $6 million on June 24, 2024, to boost operations and expansion.

Peraso Inc.'s recent achievements, coupled with the strong market potential of other emerging companies like FFIE, GDC, INBS and KAVL highlight a dynamic landscape of innovation and growth. As these companies continue to push the boundaries of their respective industries, they present compelling opportunities for investors looking to capitalize on technological advancements and market momentum. With Peraso leading the charge in mmWave technology and Ladenburg Thalmann's bullish outlook, the company is well-positioned for substantial future gains, making it a key player to watch in the evolving tech sector.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peraso-inc-nasdaq-prso-rockets-forward-ladenburg-thalmann-issues-report-amid-explosive-q2-growth-mmwave-surge-ffie-gdc-inbs-kavl]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Peraso Inc. (NASDAQ: PRSO) Rockets Forward: Ladenburg Thalmann Issues Report Amid Explosive Q2 Growth, mmWave Surge FFIE, GDC, INBS, KAVL here

News-ID: 3632011 • Views:

More Releases from ABNewswire

Prince Health Introduces PlaqueX IV Therapy in The Woodlands for Cardiovascular and Metabolic Wellness
12-20-2025 | Sports
ABNewswire
Prince Health Introduces PlaqueX IV Therapy in The Woodlands for Cardiovascular …
Prince Health in The Woodlands, TX, announces the launch of PlaqueX IV therapy, a non-surgical functional medicine treatment designed to support heart health and reduce arterial plaque. Led by Dr. Ashley Prince, DC, the practice offers this advanced phosphatidylcholine infusion to help patients improve circulation and lipid metabolism. This proactive cardiovascular solution is now available to residents in the Greater Houston area. THE WOODLANDS, Texas - December 19, 2025 - Prince
From London Comforts to Vietnamese Chaos: Author Jane Roberts Unveils the Gritty Reality of Chasing a Global Dream
From London Comforts to Vietnamese Chaos: Author Jane Roberts Unveils the Gritty …
When a high-stakes job offer in Hanoi disrupts a settled life in the UK, one woman abandons her safety net to build a market-leading empire amidst humidity, hardship, and the unknown-proving that true transformation only happens when you stop playing it safe. In her powerful debut, Follow Your Dreams: Dare to Venture into the Unknown, Jane Roberts brings us a compelling narrative about the transformative power of chasing your dreams, even
Mount Pleasant Chiropractic Practice Now Accepting New Patients for Advanced Plantar Fasciitis Treatment Protocol
12-20-2025 | Sports
ABNewswire
Mount Pleasant Chiropractic Practice Now Accepting New Patients for Advanced Pla …
Integra Health, led by Dr. Noble Thomas, DC, MSACN, has launched a specialized treatment protocol for residents seeking plantar fasciitis treatment in Mount Pleasant, NY. This comprehensive, non-surgical approach combines chiropractic care, shockwave therapy, and functional rehabilitation to address the root causes of chronic heel pain. By focusing on the whole kinetic chain, Integra Health provides Westchester County patients with a drug-free path to improved mobility and long-term relief. MOUNT PLEASANT,
Southlake Primary Care Clinic Offering Hormone Replacement Therapy to Help Patients Restore Health
12-20-2025 | Sports
ABNewswire
Southlake Primary Care Clinic Offering Hormone Replacement Therapy to Help Patie …
Southlake's Elixir 360 Health expands its services with Bioidentical Hormone Replacement Therapy (BHRT) for men and women. Addressing symptoms like fatigue, weight gain, and mental fog, the practice offers personalized, plant-based hormone protocols molecularly identical to the body's natural chemistry. Led by Raj Agarwal, Elixir 360 Health provides DFW residents with advanced regenerative medicine and customized care to restore vitality and hormonal balance. SOUTHLAKE, Texas - December 19, 2024 - Elixir

All 5 Releases


More Releases for Peraso

Undervalued Tech: Peraso Inc's (NASDAQ: PRSO) True Value Signals Upside - More S …
Mobix Labs recently made the kind of mistake that reveals more about the bidder than the target. Their unsolicited acquisition [https://www.stocktitan.net/news/PRSO/peraso-confirms-receipt-of-unsolicited-non-binding-acquisition-pevb9rjomb71.html] offer for Peraso represents classic bottom-feeding behavior. A 20% premium that exploits market pressure rather than recognizing strategic value. This follows their established pattern of lowball offers to multiple companies. Mobix declined to sign standard confidentiality agreements, indicating they never intended serious due diligence. The timing reveals everything. PerasoInc's (NASDAQ:
Peraso Inc. (NASDAQ: PRSO) Signals Turnaround - Reports Financials August 11, 20 …
Peraso Inc. (NASDAQ: PRSO) a fundamental growth story-driven by military contracts, commercial wins, and sector diversification-is even more compelling. Over the past year, Peraso has strategically expanded its footprint, building a foundation for long-term growth powered by its proprietary 60GHz mmWave technology. Defense Sector: Stealthy Solutions for Modern Battlefields Peraso Inc.'s (NASDAQ: PRSO) entry into the defense sector marks a key inflection point, with its Perspectus module-featuring stealth, low-jamming, narrow-beamforming, and week-long
Peraso (NASDAQ: PRSO) Volume Surges on Takeover News - More Stocks Inside
Mobix Labs, Inc. (NASDAQ: MOBX) has launched an unsolicited, non-binding proposal to acquire Peraso Inc. (NASDAQ: PRSO) in a stock-for-stock deal offering Peraso shareholders a 20% premium over the company's 30-day average share price. The proposed merger would create a stronger player in the high-growth mmWave, defense, and 5G semiconductor sectors-combining Mobix's $10.7M revenue base and ~450% YoY growth with Peraso's accelerating mmWave performance. The combined company is expected to generate
Peraso Inc.'s (NASDAQ: PRSO) Beamforming Technology Gains Military Traction - Se …
Peraso Inc.'s (NASDAQ: PRSO) advanced beamforming technology has proven to be a game-changer in military and dense urban deployments, where secure, reliable, and high-performance communication is critical. Beamforming's ability to direct signals with precision and bend them around obstacles not only maximizes efficiency but also makes transmissions exceptionally difficult to detect or intercept. These stealth capabilities, combined with Peraso's proprietary innovations, have enabled its solutions to excel in active war
Peraso Inc.'s (NASDAQ: PRSO) PERSPECTUS Modules Outperform in 60Ghz FWA Market
Introduction As high-speed internet access spreads around the world, the unlicensed 60GHz (57-71 Ghz) millimeter-wave (mmWave) spectrum offers immense potential for low-cost, low-capex, easily-deployed high-speed wireless communication, especially areas currently underserved by traditional broadband distribution-fiberoptic. Further, However, until recently, purchasing devices to adequately provide mmWave communications for 60Ghz/mmWave broadband deployments has been difficult. Peraso and several other companies have developed and ramped up mass manufacturing of viable 60Ghz solutions for this
Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, …
On Tuesday, June 11th, Peraso Inc. (NASDAQ: PRSO) Director Ian McWalter acquired 100,000 shares of the company's stock at an average price of $1.27 per share, totalling $127,000. This strategic investment increases McWalter's holdings to 101,246 shares. Image: https://www.abnewswire.com/uploads/9a500d398df4ec1d757968c73f802240.jpg On June 12, 2024, Ladenburg Thalmann, a renowned Wall Street firm since 1876, initiated coverage [https://thestreetreports.com/wp-content/uploads/2024/06/PRSO-Updated-research.pdf] of Peraso Inc. (NASDAQ: PRSO). Research by Grandview Research in January 2024 highlighted the global mmWave market's